Related Experiment Video
Updated: Apr 21, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
E-CIGARETTE FLAVOR RESTRICTIONS' EFFECTS ON TOBACCO PRODUCT SALES
Abigail S Friedman1, Alex C Liber2, Alyssa Crippen1
1Department of Health Policy and Management, Yale School of Public Health.
Flavor restrictions on electronic nicotine delivery systems (ENDS) reduce ENDS sales but increase combustible cigarette sales, potentially offsetting public health gains. This study examines the impact of these tobacco policies.
Area of Science:
- Public Health
- Tobacco Control
- Health Economics
Background:
- Over 385 US localities and 7 states have enacted flavored electronic nicotine delivery systems (ENDS) sales restrictions.
- The public health impact of these flavor policies remains incompletely understood.
Purpose of the Study:
- To estimate the effects of ENDS flavor restrictions on sales of both ENDS and combustible cigarettes.
- To analyze the net public health implications of these tobacco control policies.
Main Methods:
- Utilized comprehensive data linking tobacco product flavor policies to retail sales data.
- Analyzed sales data from January 2018 through March 2023.
- Estimated the impact of flavor restrictions on ENDS and cigarette sales volumes.
Main Results:
- ENDS flavor restrictions led to substantial decreases in total ENDS sales, driven by declines in flavored ENDS.
- A significant increase in combustible cigarette sales was observed: 11-15 additional cigarettes sold per 0.7 mL ENDS pod reduction.
- The rise in cigarette sales was concentrated in non-menthol brands, including those popular among underage youth.
Conclusions:
- The public health benefits of reducing ENDS sales through flavor restrictions may be counteracted by increased cigarette consumption.
- Flavor restriction policies warrant careful consideration of potential unintended consequences on the sales of more harmful tobacco products.
- Further research is needed to understand the long-term health outcomes associated with these policy-induced shifts in product use.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Regulation
CNS Depressants: Alcohol and Nicotine
FDA Approved Drugs: Changes to Approved Drugs
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...